[Cryopreservation of eggs and sperm in patients initiating cancer therapy that may affect fertility]
Larrea Bonavento N, Bardach A, Lazo E, Colaci C, Alfie V, Ciapponi A, Augustovski F, García Martí S, Alcaraz A, Pichon Riviere A
Record ID 32018004421
Spanish
Original Title:
Criopreservación de gametas en pacientes que iniciarán terapia oncológica que puede afectar la fertilidad
Authors' recommendations:
Moderate-quality evidence shows that egg and sperm preservation in patients who will initiate cancer therapy that may affect fertility, may produce a higher net benefit because it allows procreation in approximately one every four women and one every two men who used the cryopreserved eggs and sperm collected before initiating cancer therapy.
All clinical practice guidelines reviewed agree that cryopreservation of eggs and sperm should be considered as standard of care for patients who will undergo cancer therapy that may affect their fertility. In addition, they highlight the importance of early fertility counseling.
Among the coverage policies surveyed, health and private funders from high-income
countries as well as some Latin-American public funders do cover this procedure. In
Argentina, Law 26,862 considers cryopreservation of eggs and sperm for medical reasons.
No cost-effectiveness studies have been found in the search performed.
Details
Project Status:
Completed
Year Published:
2022
URL for published report:
https://www.iecs.org.ar/publicacion/?id=22254
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Argentina
MeSH Terms
- Fertility Preservation
- Oocytes
- Sperm Banks
- Neoplasms
- Fertility
- Cryopreservation
- Semen Preservation
Contact
Organisation Name:
Institute for Clinical Effectiveness and Health Policy
Contact Address:
Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name:
info@iecs.org.ar
Contact Email:
info@iecs.org.ar
Copyright:
Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.